Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.31 +0.11 (+5.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Preferred Shares (2017)

Updated

Rocket Pharmaceuticals' Preferred Shares came in at $41.47 million for Q4 2017.

Analysis

Rocket Pharmaceuticals (RCKT) Preferred Shares (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Rocket Pharmaceuticals 258.98 Mn -24.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 41.47 Mn
API Access

Rocket Pharmaceuticals Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=RCKT&period=max&api_key=YOUR_API_KEY